URO TODAY: Recurrence of prostate tumours starts no later than 58 days in the course of radiotherapy for prostate cancer, according to a new study. READ MORE>
Archive for the ‘Biochemical recurrence’ Category
Prostate cancer recurrence during radiotherapy starts less than two months in
Posted in Biochemical recurrence, Radiotherapy, tagged cancer research, catheter, catheterisation, male catheters, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate catheter, prostate tumours, Radiotherapy, recurrence, URO TODAY on September 12, 2010| Leave a Comment »
Prostate cancer patients with Gleason score 6 very unlikely to develop late recurrence
Posted in Biochemical recurrence, tagged cancer research, catheter, five-year mark, Gleason score 6, late recurrence, less-intense follow-up, prostablog, prostate, prostate blog, PROSTATE CANCER on September 5, 2010| Leave a Comment »
URO TODAY: Prostate cancer patients with Gleason score 6 disease are very unlikely to develop late recurrence and might be candidates for less-intense follow-up once they have passed the five-year mark. READ MORE>
Most men whose prostate cancer recurs still survive
Posted in Biochemical recurrence, tagged Biochemical recurrence, cancer research, catheter, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate recurs, prostate survival, REUTERS, US veterans on August 29, 2010| Leave a Comment »
REUTERS: Men who show signs that their disease has returned after prostate cancer treatment are still more likely to die of other causes, a new study in US veterans shows. READ MORE>
Researchers question need for annual PSA tests on ‘low risk’ patients after prostate surgery
Posted in Biochemical recurrence, PSA tests, tagged annual PSA testing, biochemical failure, blood test, blood tests, cancer research, catheter, low-risk patients, medical checkups, Mike Scott, New Prostate Cancer Info-link, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate-specific antigen, PSA, PSA test, PSA undetectable, Tollefson et al. on August 6, 2010| Leave a Comment »
NEW PROSTATE CANCER INFOLINK: How often after prostate surgery should a “low risk” patient have his PSA tested to check if the cancer is coming back? READ MORE>
Tollefson et al. conclude that, in low-risk patients, the risk of biochemical failure is inversely proportional to time for which the PSA is undetectable after radical prostatectomy.
They go on to suggest that taking PSA levels every two years should be sufficient to identify the majority of low-risk patients who experience biochemical progression.
The “New” Prostate Cancer InfoLink would certainly agree that annual PSA testing is probably unnecessary in the majority of patients who are treated surgically for low-risk disease if their PSA is undetectable after surgery.
However, the key question is how long should annual PSA testing be carried out before the patient can be switched to testing every two (or perhaps even every three) years.
Based on this paper, it would seem likely that even low-risk patients should all receive at least annual testing for three years after surgery.
Gene variation gives one in five men greater risk of prostate cancer recurrence
Posted in Biochemical recurrence, tagged A/G genotype of rs10895304, adjuvant radiation therapy, cancer research, catheter, decreased recurrence-free survival, DNA variation, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Radical prostatectomy, URO TODAY, Vanderbilt University on July 31, 2010| Leave a Comment »
URO TODAY: One in five men have a DNA variation that increases the risk of prostate cancer recurring after surgery, even though other factors (early diagnosis, low aggression, etc) may be in their favour. READ MORE> and HERE>
Department of Radiation Oncology, Vanderbilt University, Nashville, US:
The A/G genotype of rs10895304 is predictive of decreased recurrence-free survival in patients with clinically localised prostate cancer.Our data suggest that for this subset of patients, prostatectomy alone may not be adequate for local control.
This is a novel and relevant marker that should be evaluated for improved risk stratification of patients who may be candidates for adjuvant radiation therapy to improve local control.
Bigger the prostate tumour removed, greater the risk of recurrence
Posted in Biochemical recurrence, tagged Biochemical recurrence, cancer research, catheter, prostablog, prostate, prostate blog, PROSTATE CANCER, Radical prostatectomy, tumour size on July 9, 2010| Leave a Comment »
URO TODAY: The size of your prostate tumour may predict whether you’ll get a recurrence of the disease after a prostatectomy – the bigger the tumour, the more the risk. READ MORE>
Active surveillance may not be wise choice for younger men with low risk prostate cancer
Posted in Biochemical recurrence, PROSTATE CANCER, PROSTATE RESEARCH, Watchful waiting, tagged "long" life expectancies, active surveillance, Biochemical recurrence, cancer research, catheter, comparison of treatments, low-risk disease, low-risk prostate cancer, prostablog, prostate, prostate blog, prostate cancer treatments, prostate treatment debate, URO TODAY, Watchful waiting on June 20, 2010| Leave a Comment »
URO TODAY: Watchful waiting may not be a wise choice for younger men diagnosed with low risk prostate cancer, a new study suggests.
Our pathologic findings and risk of biochemical recurrence after open radical prostatectomy question the wisdom of active surveillance in men with low-risk disease who have “long” life expectancies. READ MORE>
